RETINAI
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
RETINAI
Industry:
Artificial Intelligence Cloud Computing Health Care Health Diagnostics Information Technology Machine Learning Software
Founded:
2016-12-16
Address:
Bern, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.retinai.com
Total Employee:
11+
Status:
Active
Total Funding:
2.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Enlitic
Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.
Medius Health
Medius’ comprehensive medical knowledge graph helps providers & payors gain thorough understanding of customer’s health.
togetherAI
TogetherAI helps protect kids online and supports families to connect and communicate about mental health and well-being.
Current Advisors List
Board_member
2019-06-01
Board_member
2020-06-01
Current Employees Featured
Carlos Ciller Co-Founder & CEO @ Retinai
Co-Founder & CEO
2017-01-01
Stefanos Apostolopoulos CTO @ Retinai
CTO
2017-04-01
Sandro Zanet Chief Scientific Officer @ Retinai
Chief Scientific Officer
2017-03-01
Founder
Investors List
Verve Ventures
Verve Ventures investment in Seed Round - Retinai
btov Partners
btov Partners investment in Seed Round - Retinai
Eurostars
Eurostars investment in Grant - Retinai
Venture Kick
Venture Kick investment in Seed Round - Retinai
Venture Kick
Venture Kick investment in Grant - Retinai
Venture Kick
Venture Kick investment in Grant - Retinai
Official Site Inspections
http://www.retinai.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Retinai"
RetinAI - LinkedIn
RetinAI | 14,090 followers on LinkedIn. Improving R&D of first-in-human drug candidates in pharma. Supercharging clinical trials. Elevating the quality of care. | RetinAI is a Swiss & US-based ...See details»
Retinai - Crunchbase Company Profile & Funding
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to …See details»
RetinAI Company Profile - Office Locations, Competitors ... - Craft
RetinAI Medical is a company that develops healthcare solutions to protect patients from vision loss using artificial intelligence. The company builds software tools to collect, organize and …See details»
RetinAI Medical GmbH - VentureRadar
Ikerian AG Switzerland Privately Held Ikerian AG, formerly known as RetinAI Medical AG, is the parent company of RetinAI U.S., a developer of software solutions for medical image and data …See details»
Retinai - Company Portfolio
Jul 8, 2024 RetinAI’s AI models are built on real-world evidence and have been rigorously validated against expert graders, achieving similar performance levels. The CE-marked …See details»
RetinAI and Retina Consultants of America Join Forces to
Jul 25, 2023 RetinAI Medical AG (RetinAI), founded in early 2017, is a Swiss company developing software solutions to accelerate clinical, research and pharmaceutical workflows …See details»
RetinAI Medical - Overview, News & Similar companies - ZoomInfo
Dec 1, 2022 RetinAI Medical AG (RetinAI), founded in early 2017, is a Swiss company developing software solutions to accelerate clinics, research and pharmaceu tical workflows …See details»
Discovery platform by RetinaAI debuts to boost …
Feb 22, 2024 RetinAI Discovery for Clinics enhances clinical workflows with AI models, improving decision-making, teleophthalmology, and patient management for ophthalmologists and optometrists. ... David Geffen School of Medicine at …See details»
RetinAI debuts Discovery platform to boost ophthalmic …
Feb 21, 2024 Ikerian AG and RetinAI Inc. US has launched RetinAI Discovery for Clinics, with two product versions to address the needs of Ophthalmologists and Optometrists. ... David Geffen School of Medicine at UCLA, said the …See details»
About Us - RetinAI
RetinAI develops software solutions to generate and organize insights and knowledge to improve patient outcomes. We provide end-to-end digital solutions to accelerate R&D of first-in-human drug candidates, supercharge clinical …See details»
Retinai Reviews: Use Cases, Pricing & Alternatives - Futurepedia
RetinAI is a transformative AI and data management platform designed specifically for the healthcare sector, particularly focusing on ophthalmology. ... RetinAI offers tailored pricing …See details»
RetinAI Medical joins non-profit macular degeneration initiative
Nov 29, 2023 RetinAI Medical, a Swiss developer of software for accelerating retinal disease R&D, has joined the Ryan Initiative for Macular Research, a non-profit consortium working on …See details»
RetinAI, Retina Consultants of America team up to build US-based …
Jul 25, 2023 RCA and RetinAI will generate RWE in retinal diseases such as age-related macular degeneration (AMD) - including intermediate AMD (iAMD), geographic atrophy (GA) …See details»
RetinAI and Boehringer Ingelheim partner to further AI …
Apr 21, 2023 RetinAI partners with experts in ophthalmology to help accelerate data analysis and achieve target-based research for improved study design, clinical studies, and research. …See details»
RetinAI Discovery® platform and AI tools launched to improve …
Feb 20, 2024 Bern, Switzerland and Boston, U.S.A., 20 February 2024 - Ikerian AG and RetinAI Inc. US (“RetinAI”), a leader in developing software solutions for image processing and …See details»
Retinai - Funding, Financials, Valuation & Investors - Crunchbase
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
RetinAI receives FDA Clearance for Discovery, our medical image …
Bern, Switzerland, May 1st, 2022. RetinAI Medical AG (“RetinAI”) today announces U.S. Food and Drug Administration (FDA) 510(k) clearance of RetinAI Discovery ®, the company’s image …See details»
RetinAI | Intelligence in Ophthalmology
Jul 25, 2023 Enable participative research accross your organization with a secured cloud-based access to data. The town square for data, medical and digital teams. Learn more. ... We are …See details»
Evolving OpenAI’s structure
4 days ago An update from the OpenAI board on transitioning its for-profit entity to a Public Benefit Corporation, reinforcing its mission-driven structure under nonprofit oversight while …See details»
What OpenAI’s restructuring plan means for its corporate future
3 days ago Currently, OpenAI’s nonprofit board governs the organization’s for-profit operations. Under the new plan, OpenAI’s for-profit arm will become a public benefit corporation (PBC) but …See details»